Provenge approved for the treatment of advanced prostate cancer - ONA
Links shared publicly online about this topic.
- 1,204total visits
Provenge approved for the treatment of advanced prostate cancer - ONA
View full resource at oncologynurseadvisor.com
Tags: Cancer, Prostate Cancer, Prostate Cancer Medication, Prostate, Men's Health, Provenge
Most Recently Shared on April 29, 2010 at 8:08 pm By:
Provenge approved for the treatment of advanced prostate cancer http://goo.gl/fb/DYeCI
Have you ever prescribed sipuleucel-T for a prostate cancer patient? - Renal and Urology News
renalandurologynews.com — “Nearly two years have passed since the FDA approved sipuleucel-T—a therapeutic cancer vaccine developed and marketed by Dendreon Corp.” View full resource at renalandurologynews.com
Most Recently Shared on March 17, 2012 at 4:02 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Have you ever prescribed Provenge for prostate cancer treatment? http://t.co/aOUCzvUG #HCsm
FDA: 35 innovative new drugs approved in fiscal year 2011
fda.gov — “Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines. This is among the highest number of approvals in the past decade, surpassed only by 2009 (37). Many of the drugs are important advances for patients, including: two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years.” View full resource at fda.gov
Most Recently Shared on November 3, 2011 at 4:08 pm By:
Paul W. Thomas Health Communicator
RT @fda_drug_info: FDA: 35 innovative new drugs approved in fiscal year 2011. http://t.co/8V8E88Lr
Zytiga creeps up on Provenge prostate-cancer drug | Reuters
reuters.com — “NEW YORK (Reuters) - Interest in Dendreon Corp's Provenge vaccine to treat prostate cancer seems to be waning following recent approval of Johnson & Johnson's more-convenient and faster-acting Zytiga treatment,” View full resource at reuters.com
Most Recently Shared on October 7, 2011 at 7:27 pm By:
Zytiga creeps up on Provenge prostate-cancer drug http://t.co/KgWsuQD5
New treatment helps Millcreek Township man fight prostate cancer | GoErie.com/Erie Times-News
goerie.com — “Russell Wertz spent part of his Thursday sitting among a couple of dozen chemotherapy patients at the Regional Cancer Center. Wertz wasn't getting chemotherapy, however. The 72-year-old Millcreek Township man received a new therapeutic vaccine to keep his advanced prostate cancer at bay. The vaccine, called Provenge, dripped from an intravenous bag into his right arm. 'It's so much easier than chemo,' Wertz said. 'We're using my own immune system to fight this disease.'” View full resource at goerie.com
Most Recently Shared on August 23, 2011 at 4:39 am By:
New treatment helps Millcreek Township man fight prostate cancer http://t.co/ncQk2s3
Dendreon Corporation CEO Mitchell H. Gold to Receive 2011 Grace Award from Cancer Research Institute
newswise.com — “Cancer Research Institute will give the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research to Mitchell H. Gold, president and CEO of Dendreon Corporation, to celebrate the FDA approval of the company's prostate cancer vaccine, Provenge, the first FDA-approved therapeutic cancer vaccine” View full resource at newswise.com
Most Recently Shared on August 17, 2011 at 6:30 pm By:
newswise Health Communicator and Health News
Dendreon Corporation CEO Mitchell H. Gold to Receive 2011 Grace Award from Cancer Research Institute: Cancer Res... http://t.co/w6oWSLD
Prostate Cancer Treatment Provenge Approved by Medicare | ThirdAge
thirdage.com — “The prostate cancer treatment Provenge will be paid for by Medicare, it announced in a statement on Jun 30.” View full resource at thirdage.com
Most Recently Shared on July 2, 2011 at 9:42 pm By:
Prostate Cancer Treatment Provenge Approved by Medicare http://bit.ly/izOKXV
Medical News: Medicare Will Pay for Provenge - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “WASHINGTON -- Medicare will pay for the immunotherapeutic agent sipuleucel-T (Provenge) for the treatment of advanced castrate resistant prostate cancer treatment, the Centers for Medicare and Medica” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2011 at 7:02 pm By:
Patricia Grace Eldercare Expert
Medicare Will Pay for Provenge: WASHINGTON (MedPage Today) -- Medicare will pay for the immunotherapeutic agent... http://bit.ly/lctBG2
Prostate cancer: Provenge gets Medicare coverage - latimes.com
latimes.com — “The Centers for Medicare and Medicaid said it would begin to cover Provenge for advanced prostate cancer -- and that it will continue paying for Avastin.” View full resource at latimes.com
Most Recently Shared on July 1, 2011 at 6:33 pm By:
LA Times Health News Health News
Prostate cancer treatment Provenge to be covered by Medicare, as is Avastin http://lat.ms/mTpJZX
Medical News: Medicare Will Pay for Provenge - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “WASHINGTON -- Medicare will pay for the immunotherapeutic agent sipuleucel-T (Provenge) for the treatment of advanced castrate resistant prostate cancer treatment, the Centers for Medicare and Medica” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2011 at 6:31 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday Medicare Will Pay for Provenge http://bit.ly/jNVQyA #medical #Health
Medicare Expands Treatment Options For Patients With Advanced Prostate Cancer
medicalnewstoday.com — “Medicare patients with metastatic prostate cancer can get a first-of-its kind treatment just approved by the Food and Drug Administration, under a final coverage decision issued today by the Cente” View full resource at medicalnewstoday.com
Most Recently Shared on July 1, 2011 at 9:05 am By:
Medicare Expands Treatment Options For Patients With Advanced Prostate Cancer http://mnt.to/3XSQ #urology
Decision Memo for Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer (CAG-00422N)
cms.gov — “Use this page to view details for the decision Memo for Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer (CAG-00422N).” View full resource at cms.gov
Most Recently Shared on June 30, 2011 at 8:41 pm By:
Luke Timmerman Health Communicator
RT @msgtretusaf: RT @HEALTH_NOTES $DNDN & #Provenge #CMS approves use http://t.co/RwL36Oc $$
Lupron Depot-6 Month 45mg Approved - MPR
empr.com — “Abbott announced that the FDA has approved a 45mg for six-month administration formulation of Lupron Depot (leuprolide acetate for depot suspension) for the palliative treatment of advanced prostate cancer.” View full resource at empr.com
Most Recently Shared on June 21, 2011 at 2:20 pm By:
MPR News: Lupron Depot-6 Month 45mg Approved: Abbott announced that the FDA has approved a 45mg for six-month ad... http://bit.ly/jcz3E5
Almost Half Of Surveyed Urologists View The Approval Of Provenge As A Breakthrough In The Treatment Of Prostate Cancer
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that nearly half of surveyed urologists view the approval of Dendreon's P” View full resource at medicalnewstoday.com
Most Recently Shared on June 15, 2011 at 3:05 pm By:
Almost Half Of Surveyed Urologists View The Approval Of Provenge As A Breakthrough In The Treatment Of Prostate Cancer http://mnt.to/3XdM
Prostate cancer treatment: New Hope For Patients with advanced widespread prostate cancer | What is Radiation therapy for cancer?
curingcancerofthemind.com — “ Zytiga, a new drug approved by the Food and Drug Administration a few days ago, gives men with advanced hormone-resistant prostate cancer a better” View full resource at curingcancerofthemind.com
Most Recently Shared on June 1, 2011 at 11:23 pm By:
Ramesh Kumar Doctor, Oncologist, Radiation Oncologist, and Physician
Prostate cancer treatment: New Hope For Patients with advanced widespread prostate cancer http://bit.ly/jju3eW
New options for prostate cancer treatment in Myrtle Beach | SCNOW
www2.scnow.com — “MYRTLE BEACH,SC- Provenge is the first FDA-approved immunotherapy for men with certain forms of advanced prostate cancer that is proven to prolong life.” View full resource at www2.scnow.com
Most Recently Shared on May 23, 2011 at 9:57 pm By:
New options for prostate cancer treatment in Myrtle Beach http://bit.ly/lRFPep
Advertisement
